Skip to main content
Erschienen in: La radiologia medica 1/2018

01.01.2018 | ONCOLOGY IMAGING

Heterogeneity analysis of diffusion-weighted MRI for prediction and assessment of microstructural changes early after one cycle of induction chemotherapy in nasopharyngeal cancer patients

verfasst von: Manijeh Beigi, Anahita Fathi Kazerooni, Mojtaba Safari, Marzieh Alamolhoda, Mohsen Shojaee Moghdam, Shiva Moghadam, Hamidreza SalighehRad, Ahmad Ameri

Erschienen in: La radiologia medica | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate whether the pretreatment apparent diffusion coefficient (ADC) heterogeneity parameters and their alterations, after one cycle of induction chemotherapy, can be used as reliable markers of treatment response to induction chemotherapy in patients with nasopharyngeal cancer.

Materials and methods

Ten patients were recruited and received induction chemotherapy (IC). Diffusion-weighted imaging was performed prior to, during, and after IC. The first-order ADC histogram parameters at the intra-treatment time-point were compared to the baseline time-point in the metastatic lymph nodes (LNs). Some ADC pretreatment parameters were combined with each other, employing discriminant analysis to achieve a feasible model to separate the complete response (CR) from the partial response (PR) groups.

Results

For ten patients, significant rise in Mean and Txt1Mean (p = 0.048 and 0.015, respectively) was observed in the metastatic nodes following one cycle of IC. Txt5Energy significantly decreased (p = 0.002). Discriminant analysis on pretreatment parameters illustrated that Txt5Energypre was the best parameter to use to correctly classify CR and PR patients. This was followed by Txt9Percentile75pre, Txt1Meanpre, and Txt2Standard Deviationpre.

Conclusions

Our results suggest that heterogeneity metrics extracted from ADC-maps in metastatic lymph nodes, before and after IC, can be used as supplementary IC response indicators.
Literatur
1.
Zurück zum Zitat Wei WI, Sham JS (2005) Nasopharyngeal carcinoma. The Lancet 365(9476):2041–2054CrossRef Wei WI, Sham JS (2005) Nasopharyngeal carcinoma. The Lancet 365(9476):2041–2054CrossRef
2.
Zurück zum Zitat Hatakenaka M, Nakrumara K, Yabuchi H et al (2011) Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiat Oncol* Biol* Phy 81(2):339–345CrossRef Hatakenaka M, Nakrumara K, Yabuchi H et al (2011) Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiat Oncol* Biol* Phy 81(2):339–345CrossRef
3.
Zurück zum Zitat Matoba M, Tuji H, Shimode Y et al (2014) Fractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with chemoradiotherapy. Am J Neuroradiol 35(2):379–385CrossRefPubMed Matoba M, Tuji H, Shimode Y et al (2014) Fractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with chemoradiotherapy. Am J Neuroradiol 35(2):379–385CrossRefPubMed
4.
Zurück zum Zitat Powell C, Schmidth M, Marco B et al (2013) Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer. Radiother Oncol 106(1):112–117CrossRefPubMed Powell C, Schmidth M, Marco B et al (2013) Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer. Radiother Oncol 106(1):112–117CrossRefPubMed
5.
Zurück zum Zitat Lee KC, Moffat B, Schott A et al (2007) Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy. Clin Cancer Res 13(2):443–450CrossRefPubMed Lee KC, Moffat B, Schott A et al (2007) Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy. Clin Cancer Res 13(2):443–450CrossRefPubMed
6.
Zurück zum Zitat Vandecaveye V, Dirix P, De kazer F et al (2012) Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma. Int J Radiat Oncol* Biol* Phy 82(3):1098–1107CrossRef Vandecaveye V, Dirix P, De kazer F et al (2012) Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma. Int J Radiat Oncol* Biol* Phy 82(3):1098–1107CrossRef
7.
Zurück zum Zitat Yoon DY, Hwang H, Chang S et al (2009) CT, MR, US, 18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Eur Radiol 19(3):634–642CrossRefPubMed Yoon DY, Hwang H, Chang S et al (2009) CT, MR, US, 18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Eur Radiol 19(3):634–642CrossRefPubMed
8.
Zurück zum Zitat Ali TFT (2012) Neck lymph nodes: characterization with diffusion-weighted MRI. Egypt J Radiol Nucl Med 43(2):173–181CrossRef Ali TFT (2012) Neck lymph nodes: characterization with diffusion-weighted MRI. Egypt J Radiol Nucl Med 43(2):173–181CrossRef
9.
Zurück zum Zitat Eisenhauer E, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247CrossRefPubMed Eisenhauer E, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247CrossRefPubMed
10.
Zurück zum Zitat King AD, Ahuja A, Yeung D et al (2007) Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. Radiology 245(3):806–813CrossRefPubMed King AD, Ahuja A, Yeung D et al (2007) Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. Radiology 245(3):806–813CrossRefPubMed
11.
Zurück zum Zitat Hoang JK, Choudhury KR, Chang J, Craciunescu OI, Yoo DS, Brizel David M et al (2014) Diffusion-weighted imaging for head and neck squamous cell carcinoma: quantifying repeatability to understand early treatment-induced change. Am J Roentgenol 203(5):1104–1108CrossRef Hoang JK, Choudhury KR, Chang J, Craciunescu OI, Yoo DS, Brizel David M et al (2014) Diffusion-weighted imaging for head and neck squamous cell carcinoma: quantifying repeatability to understand early treatment-induced change. Am J Roentgenol 203(5):1104–1108CrossRef
12.
Zurück zum Zitat Lee MC, Tsai HY, Chung KS, Chen MK et al (2013) Prediction of nodal metastasis in head and neck cancer using a 3T MRI ADC map. Am J Neuroradiol 34(4):864–869CrossRefPubMed Lee MC, Tsai HY, Chung KS, Chen MK et al (2013) Prediction of nodal metastasis in head and neck cancer using a 3T MRI ADC map. Am J Neuroradiol 34(4):864–869CrossRefPubMed
13.
Zurück zum Zitat Kim S, Loevner L, Quon H et al (2009) Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 15(3):986–994CrossRefPubMedPubMedCentral Kim S, Loevner L, Quon H et al (2009) Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 15(3):986–994CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Chawla S et al (2013) Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck. AJR Am J Roentgenol 200(1):35CrossRefPubMedPubMedCentral Chawla S et al (2013) Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck. AJR Am J Roentgenol 200(1):35CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Chen Y, Liu X, Zheng D et al (2014) Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma. Magn Reson Imaging 32(6):630–637CrossRefPubMed Chen Y, Liu X, Zheng D et al (2014) Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma. Magn Reson Imaging 32(6):630–637CrossRefPubMed
16.
Zurück zum Zitat Ohgiya Y, Suyama J, Seino N et al (2010) MRI of the neck at 3 Tesla using the periodically rotated overlapping parallel lines with enhanced reconstruction (PROPELLER)(BLADE) sequence compared with T2-weighted fast spin-echo sequence. J Magn Reson Imaging 32(5):1061–1067CrossRefPubMed Ohgiya Y, Suyama J, Seino N et al (2010) MRI of the neck at 3 Tesla using the periodically rotated overlapping parallel lines with enhanced reconstruction (PROPELLER)(BLADE) sequence compared with T2-weighted fast spin-echo sequence. J Magn Reson Imaging 32(5):1061–1067CrossRefPubMed
Metadaten
Titel
Heterogeneity analysis of diffusion-weighted MRI for prediction and assessment of microstructural changes early after one cycle of induction chemotherapy in nasopharyngeal cancer patients
verfasst von
Manijeh Beigi
Anahita Fathi Kazerooni
Mojtaba Safari
Marzieh Alamolhoda
Mohsen Shojaee Moghdam
Shiva Moghadam
Hamidreza SalighehRad
Ahmad Ameri
Publikationsdatum
01.01.2018
Verlag
Springer Milan
Erschienen in
La radiologia medica / Ausgabe 1/2018
Print ISSN: 0033-8362
Elektronische ISSN: 1826-6983
DOI
https://doi.org/10.1007/s11547-017-0808-9

Weitere Artikel der Ausgabe 1/2018

La radiologia medica 1/2018 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.